ARA-290 (aka Cibinetide) is a synthetic peptide derived from erythropoietin (EPO) designed to activate the innate repair receptor (IRR) and produce anti-inflammatory, neuroprotective, and tissue-repair effects without EPO’s red bood-cell-stimulating or pro-thrombotic actions.
For research purposes only. This product is supplied exclusively for scientific laboratory research and analytical purposes. It is not intended for human or animal use, and must not be misused in any way that contravenes MHRA regulations or applicable laws.
Secured and trusted checkout with
1
Free Delivery
Free delivery on all orders above £100
2
Secure Payments
Selection of secure payments
3
Support 24/7
Contact us 24 hours a day, 7 days a week
Validate your login
ARA-290 (aka Cibinetide) is a synthetic peptide derived from erythropoietin (EPO) designed to activate the innate repair receptor (IRR) and produce anti-inflammatory, neuroprotective, and tissue-repair effects without EPO’s red bood-cell-stimulating or pro-thrombotic actions.
Benefits
Relief of neuropathic pain (especially small-fiber neuropathy)
Strong anti-inflammatory
Supports nerve repair/regeneration
Restores immune balance in autoimmune disorders
Tissue repair actions in injured, stressed, or ischemic tissues
Provides adjunctive support for metabolic diseases like Type 2 diabetes, helping nerve complications, lipid/glucose improvements
Does not produce clinically significant changes in electrolytes, liver, kidney, pancreas, erythrocytes, platelets, or leukocytes
Improves lipid and glucose metabolism in diabetics
Interactions
Concomitant use of strong immunosuppressants or biologic anti-inflammatory drugs may amplify immune modulation (caution advised)
Agents that increase angiogenesis or that affect repair/vascular pathways may theoretically have additive or synergistic effects
Given the repair/angiogenic axis, close monitoring of anticoagulent and antiplatelet medications is recommended
Concomitant use of antidiabetic agents may require dose monitoring due to a risk of hypoglycemia
Contraindications
Do not use if you are pregnant or breastfeeding
Do not use if you determine that you are hypersensitive to this peptide
Do not use if you have an active malignancy
Do not use if you have uncontrolled cardiovascular disease or are at high risk of thrombosis
Validate your login